Reframing Pharmacogenomics in Modern Oncology: From Reactive Testing to Longitudinal Care
By Houda Hachad – Cancer care is undergoing a structural transformation. Advances in early detection, targeted therapies, and immunotherapies have improved outcomes. According to the American Cancer Society, the five-year survival rate for all cancers combined has now reached 70%, reflecting meaningful progress in treatment and care delivery.
Read More